AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025)
AtaiBeckley (ATAI) reported Change in Acquisitions & Divestments of -$11.1 million for Q3 2025, up 85.12% on a YoY basis from -$6.0 million in Q3 2024, and down 200.0% sequentially from $11.1 million in Q2 2025.
AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
AtaiBeckley (ATAI) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$11.1 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 85.12% year-over-year to -$11.1 million; the trailing twelve-month figure through Sep 2025 stood at $11.3 million (down 94.14% YoY), and the FY2024 full-year result was $65.6 million, down 52.83% from the prior year.
- Change in Acquisitions & Divestments retreated to -$11.1 million in Q3 2025, from $11.1 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $226.8 million in Q4 2022 to a low of -$74.3 million in Q3 2024.
- A 4-year average of $39.2 million and a median of $17.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Peak annual rise in Change in Acquisitions & Divestments reached 377.87% in 2024, while the deepest fall reached 102.49% in 2024.
- Tracing ATAI's Change in Acquisitions & Divestments over 4 years: stood at $226.8 million in 2022, then slumped by 38.94% to $138.5 million in 2023, then slumped by 91.85% to $11.3 million in 2024, then plunged by 197.95% to -$11.1 million in 2025.
- Business Quant data shows ATAI's Change in Acquisitions & Divestments at -$11.1 million in Q3 2025, $11.1 million in Q2 2025, and $11.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | AtaiBeckley | 1.56 Bn | 1.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.29 Mn |
| Dec 31, 2024 | 11.29 Mn |
| Sep 30, 2024 | -74.35 Mn |
| Sep 30, 2024 | -74.35 Mn |
| Jun 30, 2024 | 84.78 Mn |
| Jun 30, 2024 | 84.78 Mn |
| Mar 31, 2024 | 43.84 Mn |
| Mar 31, 2024 | 43.84 Mn |
| Dec 31, 2023 | 138.50 Mn |
| Dec 31, 2023 | 138.50 Mn |
| Sep 30, 2023 | -36.72 Mn |
| Sep 30, 2023 | -36.72 Mn |
| Jun 30, 2023 | 17.74 Mn |
| Jun 30, 2023 | 17.74 Mn |
| Mar 31, 2023 | 19.46 Mn |
| Mar 31, 2023 | 19.46 Mn |